Every SEC Form 3/4/5 on record for this filer (CIK 1225165) — 5 issuers, 26 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| EYPT | EyePoint, Inc. | Director | 2019-07-16 → 2026-01-06 | 12 | $19,997 |
| AKTX | Akari Therapeutics Plc | Interim CFO · lapsed | 2024-01-02 → 2024-05-03 | 2 | — |
| SWKH | SWK Holdings Corp | Director · lapsed | 2022-02-22 → 2023-01-04 | 5 | — |
| RCOR | Renovacor, Inc. | Chief Financial Officer · lapsed | 2021-09-07 → 2022-12-05 | 6 | — |
| IIVI | II-VI INC | Director · lapsed | 2015-08-18 → 2017-04-28 | 7 | −$452,669 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| EYPT | 2024-08-20 | Buy | 2,567 | $7.79 | $19,997 | 9,967 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.